A novel fusion of SQSTM1 and FGFR1 in a patient with acute myelomonocytic leukemia with t(5;8)(q35;p11) translocation

Blood Cancer Journal

Volumn 4, Issue 12, 2014, Pages e265-

  Nakamura, Y ^a   Ito, Y ^a   Wakimoto, N ^a   Kakegawa, E ^a   Uchida, Y ^a   Bessho, M ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 1; HYBRID PROTEIN; SEQUESTOSOME 1; UNCLASSIFIED DRUG; FGFR1 PROTEIN, HUMAN; ONCOPROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SQSTM1 PROTEIN, HUMAN;

ACUTE MYELOMONOCYTIC LEUKEMIA; AGED; ANEMIA; BLAST CELL; BLOOD TRANSFUSION; BONE MARROW CELL; CASE REPORT; CHROMOSOME 8P; CHROMOSOME 8P11; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME BREAKAGE; CHROMOSOME TRANSLOCATION; DNA DETERMINATION; FUSION GENE; GENE IDENTIFICATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTRON; KARYOTYPE 46,XY; LETTER; MALE; MEGAKARYOCYTE; MONOCYTE; PATIENT REFERRAL; ACUTE MYELOBLASTIC LEUKEMIA; CHROMOSOME 5; CHROMOSOME 8; GENE TRANSLOCATION; GENETICS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGED; CHROMOSOMES, HUMAN, PAIR 5; CHROMOSOMES, HUMAN, PAIR 8; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; ONCOGENE PROTEINS, FUSION; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; TRANSLOCATION, GENETIC;

EID: 84926517994     PISSN: None     EISSN: 20445385     Source Type: Journal    
DOI: 10.1038/bcj.2014.86     Document Type: Letter

References (14)

1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. WHO Classification of Tumours of Haematopoetic and Lymphoid Tissues. IARC: Lyon, 2008.
2. Jackson CC, Medeiros LJ, Miranda RN. 8p11 myeloproliferative syndrome: a review. Hum Pathol 2010; 41: 461-476.
3. Wasag B, Lierman E, Meeus P, Cools J, Vandenberghe P. The kinase inhibitor TKI258 is active against the novel CUX-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11). Haematologica 2011; 96: 922-926.
4. Li F, Zhai Y-P, Tang Y-M, Wang L-P, Wan P-J. Identification of a novel partner gene, TPR, fused to FGFR1 in 8p11 myeloproliferative syndrome. Gene Chromosome Cancer 2012; 51: 890-897.
5. Gervais C, Dano L, Perrusson N, Helias C, Jeandidier E, Galoisy A-C et al. A translocation t(2;8)(q12;p11) fuses FGFR1 to a novel partner gene, RANBP2/ NUP358, in a myeloproliferative/myelodysplastic neoplasm. Leukemia 2013; 27: 1186-1188.
6. Geetha T, Wooten MW. Structure and functional properties of the ubiquitin binding protein p62. FEBS Lett 2002; 512: 19-24.
7. Seibenhener ML, Geetha T, Wooten MW. Sequestosome 1/p62-more than a scaffold. FEBS Lett 2007; 581: 175-179.
8. Kirkin V, McEwan DG, Novak I, Dikic I. A role for ubiquitin in selective autophagy. Mol Cell 2009; 34: 259-269.
9. Komatsu M, Kurokawa H, Waguri S, Taguchi K, Kobayashi A, Ichimura Y et al. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol 2010; 12: 213-223.
10. Laurin N, Brown JP, Morissette J, Raymond V. Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. Am J Hum Genet 2002; 70: 1582-1588.
11. Wilson MI, Gill DJ, Perisic O, Quinn MT, Williams RL. PB1 domain-mediated heterodimerization in NADPH oxidase and signaling complexes of atypical protein kinase C with Par6 and p62. Mol Cell 2003; 12: 39-50.
12. Gorello P, Starza RL, Giacomo DD, Messina M, Puzzolo MC, Crescenzi B et al. SQSTM1-NUP214: a new gene fusion in adult T-cell acute lymphoblastic leukemia. Haematologica 2010; 95: 2161-2163.
13. Takeuchi K, Soda M, Togashi Y, Ota Y, Sekiguchi Y, Hatano S et al. Identification of a novel fusion, SQSTM1-ALK, in ALK-positive large B-cell lymphoma. Haematologica 2011; 96: 464-467.
14. dAmore ES, Visco C, Menin A, Famengo B, Bonvini P, Lazzari E. STAT3 pathway is activated in ALK-positive large B-cell lymphoma carrying SQSTM1-ALK rearrangement and provides a possible therapeutic target. Am J Surg Pathol 2013; 37: 780-786.